Ann: Medgate commences European ResAppDx trial, page-166

One of the requisites is the Trail participant should not have had the vaccination. Looking at that rate of the vaccination drive, I think more than 100 million people have received a Covid shot in America. ResApp trial might take a bit longer due to this eligibility criterion. Just my opinion.

I am keener on hearing something about the Medgate trials on ResApps core product i.e ResApp-DX. That's a bedrock feature of this company and that's where the value proposition lies ( for now). I eagerly ( read patiently) wait to see how this pans out and articulated to the wider community.

COVID detection can be a good verticle, but I won't put too much weight on it, just yet.

I think the ResApp fleet should have all hands on deck to get the validated product-ResApp DX -up and running.

"A bird in the hand is better than 2 in a bush"

June 2021 seems to be a pivot month where things might get more interesting.

IMO